Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Arzneimittel-Forschung|August 1, 1994
Synthesis and biological activity of D-glucopyranosyl peptide T derivativesM Marastoni, S Spisani, R TomatisArzneimittel-Forschung|November 24, 1998
Synthesis and biological activity of chelator-peptide T conjugatesM Marastoni, S Spisani, R TomatisIl Farmaco; Edizione Scientifica|June 1, 1985
Opioid peptides. VIII. Synthesis and preliminary biological activity of [D-Phe3]- or [alpha,beta-dehydro-Phe3]dermorphin tetrapeptidesS Salvadori, M Marastoni, G Balboni, et al.Arzneimittel-Forschung|August 5, 1998
Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unitM Marastoni, F Bortolotti, S Salvadori, et al.Il Farmaco; Edizione Scientifica|September 1, 1983
Opioid peptides. Structure-activity relationships in [beta-Ala4]dermorphin tetrapeptides. VS Salvadori, M Marastoni, R Tomatis, et al.Arzneimittel-Forschung|August 5, 2000
Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitorsM Marastoni, M Bazzaro, F Bortolotti, et al.Arzneimittel-Forschung|November 1, 1996
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)tartaric acidM Marastoni, G Fantin, F Bortolotti, et al.Il Farmaco; Edizione Scientifica|August 1, 1982
Opioid peptides. Structure-activity relationships in dermorphin tetrapeptides. IS Salvadori, M Marastoni, R Tomatis, et al.The Journal of Peptide Research : Official Journal of the American Peptide Society|June 1, 1997
HIV-1 protease inhibitors containing a novel C2 symmetrical hydroxyalkylgem-diamino core structureM Marastoni, S Salvadori, F Bortolotti, et al.Arzneimittel-Forschung|July 1, 1997
Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structureM Marastoni, M Bergonzoni, F Bortolotti, et al.Pageof 7